A review of in vivo 1H magnetic resonance spectroscopy of cerebral ischemia in rats

Biochemistry and Cell Biology

Volumn 76, Issue 2-3, 1998, Pages 487-496

  Malisza, K L ^a   Kozlowski, P ^a   Peeling, J ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cerebral ischemia; In vivo; NMR; Rat

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; DICHLOROACETIC ACID; LACTIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; BIOLOGICAL MARKER; DRUG DERIVATIVE; LACTIC ACID DERIVATIVE; N-ACETYLASPARTATE; NEUROPROTECTIVE AGENT; PROTON;

BRAIN ISCHEMIA; BRAIN METABOLISM; HYPOTHERMIA; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REVIEW; STROKE; TEMPERATURE; ANIMAL; BRAIN HYPOXIA; BRAIN LEVEL; CHRONIC BRAIN DISEASE; CRYOANESTHESIA; ENERGY METABOLISM; METABOLISM; NEWBORN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROGNOSIS; REPERFUSION INJURY;

ANIMALIA;

ANIMALS; ANIMALS, NEWBORN; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CHOLINE; DICHLOROACETATE; ENERGY METABOLISM; HYPOTHERMIA, INDUCED; HYPOXIA, BRAIN; LACTATES; MAGNETIC RESONANCE SPECTROSCOPY; NEUROPROTECTIVE AGENTS; PROGNOSIS; PROTONS; RATS; REPERFUSION INJURY;

EID: 0032217330     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o98-041     Document Type: Review

References (54)

1. 1H-NMR spectroscopy. Brain Res. 643: 92-99.
2. Baker, L.L., Kucharczyk, J., Sevick, R.J., Mintorovitch, J., and Moseley, M.E. 1991. Recent advances in MR imaging/spectroscopy of cerebral ischemia. Am. J. Roentgenol. 156: 1133-1143.
3. Baslow, M.H. 1997. A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-L-aspartic acid and N-acetyl-L-histidine, in the vertebrate nervous system. J. Neurochem. 68: 1335-1344.
4. 1H NMR study of cerebral development in the rat. NMR Biomed. 2: 225-229.
5. 1H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy. Magn. Reson. Med. 17: 285-303.
6. 1H NMR spectrum of rat brain. Magn. Reson. Med. 30: 38-44.
7. Birken, D.L., and Oldendorf, W.H. 1989. N-Acelyl-L-asparlic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13: 23-31.
8. Bourgeois, D., Remy, C., LeFur, Y., Devoulon, P., Benabid, A.L., and Decorps, M. 1991. Proton spectroscopic imaging: a tool for studying intracerebral tumor models in rat. Magn. Reson. Med. 21: 10-20.
9. Brindle, K.M., Fulton, A.M., and Williams, S.-P. 1994. NMR and molecular genetics in enzyme study. In NMR in physiology and biomedicine. Edited by R.J. Gillies. Academic Press, San Diego, Calif. pp. 244-245.
10. Bruhn, H., Michaelis, T., Merboldt, K.D., Hanicke, W., Gyngell, M.L., and Frahm, J. 1991. Monitoring cerebral glucose in diabetics by proton MRS. Lancet, 337: 745-746.
11. Brulatout, S., Meric, P., Loubinoux, I., Borredon, J., Correze, J.L., Roucher, P., Gillet, B., Berenger, G., Beloeil, J.C., Tiffon, B., Mispelter, J., and Seyaz, J. 1996. A one-dimensional (proton and phosphorus) and two-dimensional (proton) in vivo NMR spectroscopic study of reversible global cerebral ischemia. J. Neurochem. 66: 2491-2499.
12. Cendes, F., Andermann, F., Dubeau, F., and Arnold, D.L. 1995. Proton magnetic resonance spectroscopic images and MRI volumetric studies for lateralization of temporal lobe epilepsy. Magn. Reson. Imaging, 13: 1187-1191.
13. Choe, B.-Y., Suh, T.-S., Shinn, K.-S., Lee, C.-W., Lee, C., and Paik, I.-H. 1996. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Investig. Radiol. 31: 345-352.
14. 31P NMR spectroscopy during repeated brief cerebral ischemia. J. Cereb. Blood Flow Metab. 15: 26-32.
15. de Graaf, A.A., Deutz, N.E.P., Bosman, D.K., Chamuleau, R.A.F.M., de Haan, J.G., and Bovee, W.M.M.J. 1991. The use of in vivo proton NMR to study the effects of hyperammonemia in the rat cerebral cortex. NMR Biomed. 4: 31-37.
16. De Stefano, N., Matthews, P.M., and Arnold, D.L. 1995. Reversible decreases in N-acetylaspartate after acute brain injury. Magn. Reson. Med. 34: 721-727.
17. Djuricic, B., Olson, S.R., Assaf, H.M., Whittingham, T.S., Lust, W.D., and Drewes, L.R. 1991. Formation of free choline in brain tissue during in vitro energy deprivation. J. Cereb. Blood Flow Metab. 11: 308-313.
18. 1H MRS of the human brain in vivo based on the simulation phantom calibration strategy. Magn. Reson. Med. 39: 491-496.
19. Duijn, J.H., Matson, G.B., Maudsely, A.A., and Weiner, M.W. 1992. 3D phase encoding 1H spectroscopic imaging of human brain. Magn. Reson. Imaging, 10: 315-319.
20. Ende, G., Knowlton, R., Laxer, K.D., Matson, G., and Weiner, M.W. 1996. NAA is a more sensitive marker of hippocampal disease than atrophy: evidence that NAA is a neuronal marker. In Proceedings of the International Society for Magnetic Resonance in Medicine, New York, N.Y., April 27 - May 3. International Society for Magnetic Resonance in Medicine, Berkeley, Calif. Abstr. No. 137.
21. 1H NMR spectroscopy and high performance liquid chromatography. Neurochem. Res. 21: 1065-1074.
22. Gideon, P., Sperling, B., Arlien-Soborg, P., Olsen, T.S., and Henriksen, O. 1994. Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke, 25: 967-973.
23. Graham, G.D., Blamire, A.M., Howseman, A.M., Rothman, D.L., Fayad, P.B., Brass, L.M., Petroff, O.A.C., Shulman, R.G., and Prichard, J.W. 1992. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke, 23: 333-340.
24. Graham, G.D., Blamire, A.M., Rothman, D.L., Brass, L.M., Fayad, P.B., Petroff, O.A.C., and Prichard, J.W. 1993. Early temporal variation of cerebral metabolites after human stroke. Stroke, 24: 1891-1896.
25. Hashimoto, T., Tayama, M., Miyazaki, M., Yoneda, Y., Yoshimoto, T., Harada, M., Miyoshi, H., Tanouchi, M., and Kuroda, Y. 1995. Reduced N-acetylaspartate in the brain observed on in vivo proton magnetic resonance spectroscopy in patients with mental retardation. Pediatr. Neurol. 13: 205-208.
26. Henriksen, O. 1995. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed. 8: 139-148.
27. Higuchi, T., Fernandez, E.J., Rooney, W.D., Gaspary, H.L., Graham, S.H., Weinstein, P.R., Maudsley, A.A., and Weiner, M.W. 1992. Regional specific changes of N-acetyl aspartate, lactate, alanine and glutamate in post globally ischemic brain. In Proceedings of the International Society for Magnetic Resonance in Medicine, Berlin, Germany, August 8-14. International Society for Magnetic Resonance in Medicine, Berkeley, Calif. Abstr. No. 547.
28. 1H magnetic resonance spectroscopy in rats. Neurosurgery (Baltim.), 38: 121-130.
29. Houkin, K., Kamada, K., Kamiyama, H., Iwasaki, Y., Abe, H., and Kashiwaba, T. 1993. Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction. Stroke, 24: 1316-1321.
30. Howe, F.A., Maxwell, R.J., Saunders, D.E., Brown, M.M., and Griffiths, J.R. 1993. Proton spectroscopy in vivo. Magn. Reson. Q. 9: 31-59.
31. Hugg, J.W., Matson, G.B., Tweig, D.B., Maudsley, A.A., Sappey-Marnier, D., and Weiner, M.W. 1992. Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn. Reson. Imaging, 10: 227-243.
32. 1H nuclear magnetic resonance spectroscopy in cortical brain slices from the guinea pig: evidence for changes in detectability during severe anoxic insults. J. Neurochem. 57: 1136-1144.
33. Kauppinen, R.A., Williams, S.R., Busza, A.L., and Van Bruggen, N. 1993. Applications of magnetic resonance spectroscopy and diffusion-weighted imaging to the study of brain biochemistry and pathology. Trends Neurosci. 16: 88-95.
34. 1H localized spectroscopy in-vivo in focal ischemia in rats. In Proceedings of the International Society for Magnetic Resonance in Medicine, Vancouver, B.C., April 12-18. International Society for Magnetic Resonance in Medicine, Berkley, Calif. Abstr. No. 1246.
35. 1H spectroscopic imaging. Magn. Reson. Med. 37: 346-354.
36. Kuhr, W.G., van den Berg, C.J., and Korf, J. 1988. In vivo identification and quantification of carrier-mediated transport of lactate at the cellular level in the striatum of conscious freely moving rats. J. Cereb. Blood Flow Metab. 8: 848-856.
37. Lanfermann, H., Kugel, H., Heindel, W., Herholz, K., Heiss, W.D., and Lackner, K. 1995. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology, 196: 203-210.
38. Nagatomo, Y., Wick, M., Prielmeier, F., and Frahm, J. 1995. Dynamic monitoring of cerebral metabolites during and after transient global ischemia in rats by quantitative proton NMR spectroscopy in vivo. NMR Biomed. 8: 265-270.
39. Payen, J.-F., LeBars, E., Wuyam, B., Tropini, B., Pepin, J.-L., Levy, P., and Decorps, M. 1996. Lactate accumulation during moderate hypoxic hypoxia in neocortical rat brain. J. Cereb. Blood Flow Metab. 16: 1345-1352.
40. 1H spectroscopic imaging for evaluating the local metabolic response to focal ischemia in the conscious rat. NMR Biomed. 5: 11-19.
41. 1H NMR spectroscopy. Magn. Reson. Med. 27: 356-361.
42. Prior, M.J.W. 1995. Nuclear magnetic resonance spectroscopy of living systems. Nucl. Magn. Reson. 24: 398-443.
43. 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed. 4: 59-63.
44. 13C] glucose infusion. Magn. Reson. Med. 21: 302-307.
45. 31P saturation transfer. J. Pharmacol. Exp. Ther. 251: 700-706.
46. Sager, T.N., Fink-Jensen, A., and Hansen, A.J. 1997. Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia. J. Neurochem. 68: 675-682.
47. Sappey-Marinier, D., Calabrese, G., Hetherington, H.P., Fisher, S.N.G., Deicken, R., Van Dyke, C., Fein, G., and Weiner, M.W. 1992. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn. Reson. Med. 26: 313-327.
48. Shimizu, H., Chang, L.-H., Litt, L., Zarow, G., and Weinstein, P.R. 1997. Effect of brain, body, and magnet bore temperatures on energy metabolism during global cerebral ischemia and reperfusion monitored by magnetic resonance spectroscopy in rats. Magn. Reson. Med. 37: 833-839.
49. Tuor, U.I., Del Bigio, M.R., and Chumas, P.D. 1996. Brain damage due to cerebral hypoxia-ischemia in the neonate: pathology and pharmacological modification. Cerebrovasc. Brain Metab. Rev. 8: 159-193.
50. Tuor, U.I., Yager, J.Y., Bascaramurty, S., and Del Bigio, M.R. 1997. Dexamethasone prevents hypoxia/ischemia-induced reductions in cerebral glucose utilization and high-energy phosphate metabolites in immature brain. J. Neurochem. 69: 1954-1963.
51. Tuor, U.I., Kozlowski, P., Del Bigio, M.R., Ramjiawan, B., Su, S., Malisza, K.L., and Saunders, J.K. 1998. Diffusion-and T2-weighted increases in magnetic resonance images of immature brain during hypoxia-ischemia: transient reversal posthypoxia. Exp. Neurol. 150: 321-328.
52. Usenius, T., Usenius, J.-P., Tanhunen, M., Vainio, P., Johansson, R., Soimakallio, S., and Kauppinen, R. 1995. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int. J. Radiat. Oncol. Biol. Phys. 33: 719-724.
53. Vannucci, R.C., and Yager, J.Y. 1992. Glucose, lactic acid and perinatal hypoxic-ischemic brain damage. Pediatr. Neurol. 8: 3-12.
54. Walz, W., and Mukerji, S. 1988. Lactate release from cultured astrocytes and neurons: a comparison. Glia, 1: 366-370.